Technical Analysis for BNR - Burning Rock Biotech Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 28.97 | -4.36% | -1.32 |
BNR closed down 4.36 percent on Friday, April 9, 2021, on 1.44 times normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Up |
| Historical BNR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| Bearish Engulfing | Bearish | 0.00% | |
| Stochastic Sell Signal | Bearish | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| 50 DMA Resistance | Bearish | -4.36% | |
| Multiple of Ten Bullish | Other | -4.36% | |
| Overbought Stochastic | Strength | -4.36% | |
| Up 3 Days in a Row | Strength | -4.36% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 23 hours ago |
| 3x Volume Pace | 1 day ago |
| 2x Volume Pace | 1 day ago |
| 1.5x Volume Pace | 1 day ago |
| Down 2 % | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/11/2021
Burning Rock Biotech develops cancer diagnostic treatment based on deoxyribonucleic acid (DNA). The company provides tumor gene detection, liquid biopsy, hereditary tumor gene detection, tumor benign, and precision clinical trail for lung cancer, breast cancer, colorectal cancer, prostatic cancer, thyroid cancer, and hereditary tumors. Burning Rock Biotech was founded in January 2014, and is based in Guangzhou, China with additional locations in Beijing and Shanghai, China.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Clinical Medicine Acid Oncology Breast Cancer Prostate Cancer Tumor Thyroid Colorectal Cancer Infectious Causes Of Cancer Lung Cancer Biopsy Thyroid Cancer Hereditary Cancers
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Clinical Medicine Acid Oncology Breast Cancer Prostate Cancer Tumor Thyroid Colorectal Cancer Infectious Causes Of Cancer Lung Cancer Biopsy Thyroid Cancer Hereditary Cancers
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 39.71 |
| 52 Week Low | 18.64 |
| Average Volume | 380,836 |
| 200-Day Moving Average | 27.05 |
| 50-Day Moving Average | 30.71 |
| 20-Day Moving Average | 26.59 |
| 10-Day Moving Average | 27.86 |
| Average True Range | 1.86 |
| ADX | 24.44 |
| +DI | 27.37 |
| -DI | 17.94 |
| Chandelier Exit (Long, 3 ATRs ) | 28.29 |
| Chandelier Exit (Short, 3 ATRs ) | 28.64 |
| Upper Bollinger Band | 30.35 |
| Lower Bollinger Band | 22.83 |
| Percent B (%b) | 0.82 |
| BandWidth | 28.26 |
| MACD Line | -0.39 |
| MACD Signal Line | -1.05 |
| MACD Histogram | 0.6594 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 32.09 | ||||
| Resistance 3 (R3) | 32.39 | 31.64 | 31.57 | ||
| Resistance 2 (R2) | 31.64 | 30.85 | 31.50 | 31.40 | |
| Resistance 1 (R1) | 30.31 | 30.36 | 29.94 | 30.01 | 31.22 |
| Pivot Point | 29.56 | 29.56 | 29.38 | 29.42 | 29.56 |
| Support 1 (S1) | 28.23 | 28.77 | 27.86 | 27.93 | 26.72 |
| Support 2 (S2) | 27.48 | 28.28 | 27.34 | 26.54 | |
| Support 3 (S3) | 26.15 | 27.48 | 26.37 | ||
| Support 4 (S4) | 25.85 |
